In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the2010-2011 season in Japan

Journal of Infection and Chemotherapy

Volumn 18, Issue 4, 2012, Pages 529-533

  Ikematsu, Hideyuki ^a,b   Kawai, Naoki ^b   Kashiwagi, Seizaburo ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b Japan Physician's Association   (Japan)

Author keywords

Influenza; Laninamivir; Oseltamivir; Peramivir; Zanamivir

Indexed keywords

LANINAMIVIR; OSELTAMIVIR; PERAMIVIR; SIALIDASE INHIBITOR; VIRUS SIALIDASE; ZANAMIVIR;

ANIMAL CELL; ARTICLE; EPIDEMIC; IC 50; IN VITRO STUDY; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; JAPAN; NASAL BIOPSY; NASOPHARYNGEAL SWAB; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROAT CULTURE; VIRUS CULTURE; VIRUS ISOLATION;

EID: 84865135279     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0377-8     Document Type: Article

References (14)

1. Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec. 2009;46:481-4.http://www.who.int/wer/2009/wer8446. pdf.
2. N Kawai H Ikematsu N Iwaki I Satoh T Kawashima T Maeda, et al. 2005 Factors influencing the effectiveness ofoseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza seasonClin Infect Dis 40 9 1309 1316 15825034 10.1086/429241 1:CAS:528:DC%2BD2MXktlajsrw%3D (Pubitemid 40570241)
3. N Kawai H Ikematsu N Iwaki T Maeda I Satoh N Hirotsu, et al. 2006 A comparison of the effectiveness of oseltamivir forthe treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasonsClin Infect Dis 43 4 439 444 16838232 10.1086/505868 1:CAS:528:DC%2BD28XovFWgsrs%3D (Pubitemid 44157151)
4. N Kawai H Ikematsu N Iwaki T Kawashima T Maeda S Mitsuoka, et al. 2007 Longer virus shedding in influenza B than ininfluenza A among outpatients treated with oseltamivir J Infect 55 267 272 17604839 10.1016/j.jinf.2007.05.176 (Pubitemid47248483)
5. A Lackenby O Hungnes SG Dudman A Meijer WJ Paget AJ Hay, et al. 2008 Emergence of resistance to oseltamivir amonginfluenza A(H1N1) viruses in Europe Euro Surveill 13 1 2
6. Influenza A virus resistance to oseltamivir and other antiviral medicines 4 June 2009.http://www.who.int/csr/disease/influenza/2008-9nhemisummaryreport/ en/.
7. LV Gubareva RG Webster FG Hayden 2001 Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 againstclinical isolates of influenza virus and neuraminidase inhibitor-resistant variants Antimicrob Agents Chemother 45 3403 340811709315 10.1128/AAC.45.12.3403-3408.2001 1:CAS:528: DC%2BD3MXovVOlsLk%3D (Pubitemid 33107853)
8. N Kawai H Ikematsu N Iwaki K Kondou N Hirotsu T Kawashima, et al. 2009 Clinical effectiveness of oseltamivir forinfluenza A (H1N1) virus with H274Y neuraminidase mutation J Infect 59 3 207 212 19619898 10.1016/j.jinf.2009.07.002
9. N Kawai H Ikematsu N Hirotsu T Maeda T Kawashima O Tanaka, et al. 2009 Clinical effectiveness of oseltamivir andzanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese multicenter study of the2007-2008 and 2008-2009 influenza seasons Clin Infect Dis 49 12 1828 1835 19911968 10.1086/6484241:CAS:528:DC%2BC3cXmvVShtg%3D%3D
10. HT Nguyen TG Sheu VP Mishin AI Klimov LV Gubareva 2010 Assessment of pandemic and seasonal influenza A (H1N1) virussusceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays Antimicrob Agents Chemother 54 36713677 20585136 10.1128/AAC.00581-10 1:CAS:528:DC%2BC3cXht12ktL7O
11. J Stockton JS Ellis M Saville JP Clewley MC Zambon 1998 Multiplex PCR for typing and subtyping influenza andrespiratory syncytial viruses J Clin Microbiol 36 2990 2995 9738055 1:CAS:528:DyaK1cXmtleltrc%3D (Pubitemid 28429426)
12. M Yamashita T Tomozawa M Kakuta A Tokumitsu H Nasu S Kubo 2008 CS-8958, a prodrug of the new neuraminidase inhibitorR-125489, shows long-acting anti-influenza virus activity Antimicrob Agents Chemother 53 186 192 1895552010.1128/AAC.00333-08
13. MJ Memoli RJ Hrabal A Hassantoufighi MC Eichelberger JK Taubenberger 2010 Rapid selection of oseltamivir- andperamivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts Clin Infect Dis 50 9 1252 1255 2034523910.1086/651605 1:CAS:528:DC%2BC3cXhtVehtL3M
14. PJ Collins LF Haire YP Lin J Liu RJ Russell PA Walker, et al. 2008 Crystal structures of oseltamivir-resistantinfluenza virus neuraminidase mutants Nature 453 1258 1261 18480754 10.1038/nature06956 1:CAS:528: DC%2BD1cXnslGks7k%3D(Pubitemid 351913590)